language_icon
EN
HI

Fredun Pharmaceuticals Share price

FREDUN

2108

64.10 (3.14%)
Last updated on 22 Apr, 2026 | 15:29 IST
Today's High

2141.00

Today's Low

2055.00

52 Week Low

655.20

52 Week High

2141.00

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Fredun Pharmaceuticals Chart

Fredun Pharmaceuticals Share Key Metrics

Volume
7793.00
Market Cap
973.24 CR
LTQ@LTP
4@2108.00
ATP
2088.9
Var Margin
22.3 %
Circuit Range
1635.15-2452.65
Delivery %
65.16 %
Value
1.63 CR
ASM/GSM
No
Market Lot
1

Summary

22 Apr, 2026 | 15:29 को, Fredun Pharmaceuticals का शेयर प्राइस आज ₹2108 पर है, जो दिन के लिए 64.10% की 3.14 दर्शाता है। स्टॉक की इंट्राडे मूवमेंट ₹2055.00 और ₹2141.00 के बीच रही है, जबकि 52‑सप्ताह के आधार पर यह ₹655.20 से ₹2141.00 तक रही है। ट्रेडिंग गतिविधि के मामले में, Fredun Pharmaceuticals ने 7793 शेयरों का वॉल्यूम रिकॉर्ड किया है, जिसका मार्केट कैपिटलाइज़ेशन ₹4761662 है। स्टॉक की एवरेज ट्रेडेड प्राइस ₹208890 है, जबकि लास्ट ट्रेडेड क्वांटिटी एट लास्ट ट्रेडेड प्राइस (LTQ@LTP) 4,210800 रही। यह स्टॉक ₹1635.15-2452.65 की सर्किट रेंज में ट्रेड करता है, और आज का कारोबार मूल्य ₹1.63 CR है। दिन के लिए डिलीवरी परसेंटेज 65.16% रही। इसके अतिरिक्त, Fredun Pharmaceuticals वर्तमान में No फ्रेमवर्क के तहत आता है और 1 के मार्केट लॉट साइज़ में ट्रेड करता

Fredun Pharmaceuticals Fundamentals

View More
P/E Ratio

34.48

P/B Ratio

4.23

Div. Yield

0.03

Sector P/E

63.84

Sector P/B

3.48

Sec. Div. Yield

0.57

Fredun Pharmaceuticals Resistance and Support

Pivot 2061.3

Resistance

First Resistance

2122.6

Second Resistance

2201.3

Third Resistance

2262.6

Support

First Support

1982.6

Second Support

1921.3

Third Support

1842.6

Fredun Pharmaceuticals Shareholding Pattern

View More
  • 2016-17
  • 2018-19
  • 2019-20
  • 2020-21
  • 2021-22
  • 2022-23
  • 2023-24
  • 2024-25
  • 2025-26
  • 2026-27
Total Promoters
Segment
Percent

Total Promoters

44.17%

Mutual Fund

0%

Insurance

0%

Foreign Institutional Investors

1.06%

Domestic Institutional Investors

2.83%

Retail

51.94%

Others

0%

Total Promoters
MAR '26
44.17%

Fredun Pharmaceuticals Corporate Actions

DateAgenda
2026-02-09Quarterly Results

Fredun Pharmaceuticals News

Fredun Pharmaceuticals Ltd - 539730 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

Fredun Pharmaceuticals' promoter group acquired 40,000 shares by converting warrants. This transaction, executed on April 9, 2026, increased their voting stake to 44.57% and their overall holding (including remaining warrants) to 45.54% of the company's capital.
Apr 15 2026 09:04:00

Fredun Pharmaceuticals Ltd - 539730 - Disclosure Under Regulation 7(2) Of SEBI (Prohibition Of Insider Trading) Regulations, 2015.

Fredun Pharmaceuticals' Director, Daulat Nariman Medhora, acquired 4 lakh equity shares for ₹5 crore. This preferential allotment increased his shareholding from 25.78% to 26.32% as part of a warrant conversion.
Apr 13 2026 18:04:00

Fredun Pharmaceuticals Ltd - 539730 - Announcement under Regulation 30 (LODR)-Allotment

Fredun Pharmaceuticals Board approved the allotment of 40,000 equity shares to promoter Mrs. Daulat Nariman Medhora. These shares, valued at ₹1250 each, were issued upon conversion of previously allotted warrants, completing a ₹3.75 crore capital raise.
Apr 09 2026 18:04:00

Fredun Pharmaceuticals Ltd - 539730 - Board Meeting Outcome for Outcome Of Board Meeting Dated 09Th April, 2026

Fredun Pharmaceuticals Board approved the allotment of 40,000 equity shares to promoter Mrs. Daulat Nariman Medhora. These shares, valued at ₹1250 each, were issued upon conversion of previously allotted warrants, completing a ₹3.75 crore capital raise.
Apr 09 2026 18:04:00

Fredun Pharmaceuticals Ltd - 539730 - Announcement under Regulation 30 (LODR)-Allotment

Fredun Pharmaceuticals board approved the allotment of 1,06,668 equity shares to Promoter Mr. Fredun Nariman Medhora on March 25, 2026. This allotment results from the conversion of warrants, with a balance consideration of ₹10.00 crore received.
Mar 25 2026 18:03:00

Fredun Pharmaceuticals Ltd - 539730 - Board Meeting Outcome for Outcome Of Board Meeting Dated 25Th March, 2026

Fredun Pharmaceuticals board approved the allotment of 1,06,668 equity shares to Promoter Mr. Fredun Nariman Medhora on March 25, 2026. This allotment results from the conversion of warrants, with a balance consideration of ₹10.00 crore received.
Mar 25 2026 17:03:00
Read More

About Fredun Pharmaceuticals AboutThe

NSE : 0  
BSE : 539730  
ISIN : INE194R01017  

FREDUN PHARMACEUTICALS LIMITED is promoted by qualified andexperienced technocrats Mr. Nariman Medhora andDr.(Mrs.)Daulat Nariman Medhora.The promoters ventured into the business nine years ago andestablished a proprietary firm by the name and style ofD.N.Pharma for manufacture and export of pharmaceuticalformulations. The exports were mainly to Afghanistan WestAfrica D.N.Pharma has over 15 branded products covering awide range of applications as follows:--------------------------------------------------------------------------BRAND NAME DOSAGE FORM BULK DRUG APPLICATION--------------------------------------------------------------------------Neozoline Nasal Drop Xylometazoline Hydrochloride Decongestant DropsDolnacid Tablets Aluminium Hyrdoxide/Magnesium Antacid Tablets Hydroxide + SimethiconeNucee Drops Vitamin C Vitamin DropsDiarnil-N- Syrup Neomycin Sulphate Kaolin. Antidarrhoeal PectinNeogesic Cream Diethylamine Salicylate Anti-inflammatory Analgesic creamNeoprofane Tablet Ibuprofen Anti-inflammatory TabletsNervigesic Tablet Analgin/Vitamin B1 B6 B12 Neurological Problem--------------------------------------------------------------------------Their products are well received in the exports markets andhave a good demand. Since 1993 D.N.Pharma''s operations havebeen phased out with a view to switch over the business toFredun Pharmaceuticals Limited henceforth known as FPL).FPL has 50% stake in D.N.Pharma. The above mentionedproducts were being manufactured by D.N.Pharma on loanlicense basis from other manufacturers.Since the Registrar Of Companies did not permit theinclusion of the initials `D & N'' in the name D.N.Pharmafor the purpose of conversion of D.N.Pharma into a LimitedCompany it was decided to convert Fredun PharmaceuticalsPrivate Limited which had been incorporated on 8th June1987 to a Public Limited Company. Subsequently FredunPharmaceutical Private Limited was converted into a PublicLimited Company on 15th March 1994 and renamed as M/SFredun Pharmaceuticals Limited.FPL has its Registered Office at 26 Manoj IndustrialPremises G.D.Ambekar Marg Wadala Mumbai 400 031. It wasset up with the objective of providing facilities for themanufacturing and marketing of various pharmaceuticalformulations such as Tablets Capsules Dry-Syrups andOintments. The Company then set up a formulation plant atPalghar District Thane which is about 75 Kms from Mumbai.The Company will be manufacturing formulations for both theDomestic as well as the International Market.FPL has been carrying out the manufacturing operations onloan license for reputed Pharmaceutical companies likeCIPLA. It has also manufactured for some merchant exportersincluding Merind. The details as on 31st August are aslisted below:------------------------------------------------------------Brand Name TIC/S* Qty/Mn) Bulk drug L/L-M/E# L/E$------------------------------------------------------------Ferovita C 10.07 Ferrous M/E E FumarateYurovite C 4.50 Ferrous M/E E Fumarate-- T 2.40 Paracetamol M/E EChemicillin C 2.10 Ampicillin L/L EChemadol T 11.00 Paracetamol L/L EMetolar T 6.50 L/L LTheobid T 20.00 Theophylline L/L LIbugesic plus T 50.00 Ibuprofen L/L L Paracetamol-- T 12.00 Ferrous M/E E Fumarate-- T 17.00 Bisacodyl M/E E-- T 1.00 Pyrazinamide M/E ENovamox C 6.40 Amoxycillin L/L LPirox DT T 2.40 Piroxicam L/L LAmidol T 8.80 Paracetamol L/L EOxacilline C 0.50 Oxacillin L/L LNorflox TZ T 6.00 Norfloxacin L/L L Tinidazole------------------------------------------------------------* : T-Tablets C-Capsules S-Syrup# : L/L-Loan License M/E-Merchant Exports$ : L-Local E-ExportThe Company aims at producing high quality products. Theproducts are manufactured as per the Good ManufacturingPractices (GMP) Norms which assures quality safety andfreedom from harmful side effects.The GMP Norms cover a number of observance of basicprinciples and steps taken for the selection and trainingof personnel personal Industrial hygiene adequacy ofbuilding and premises production equipment including itsmaintenance and validation manufacturing and packagingprocesses including standard operating procedures qualityassurance raw and packing materials labelingdistribution warehousing and documentation.The Company has been granted the GMP certificate Food andDrugs Administration Maharashtra State and has applied forthe World Health Organisation (WHO) GMP. The Company alsohas a well equipped Quality Control Laboratory which hasthe most modern equipments and instruments to undertakechemical instrumental and microbiological analysis. Theplant is manned by a team of qualified and experiencedpersonnel. The firm has obtained all proper licenses suchas License to Manufacture for Sale from the Food and DrugAdministration of the Maharashtra State.The construction of the factory building was completed in1993. The manufacturing unit commenced commercialproduction in August 1994.

Read More

Fredun Pharmaceuticals Management

NamePosition
Daisy DsouzaNon Executive Independent Director
Sonal DesaiNon Executive Independent Director
View More

Fredun Pharmaceuticals FAQs

Fredun Pharmaceuticals शेयर का खरीद मूल्य 2108 है। लाइव प्राइस और तत्काल ट्रेडिंग के लिए, आप अपने चॉइस ट्रेडिंग खाते में लॉगिन कर सकते हैं या चॉइस के साथ मुक्त डीमैट खाता खोल सकते हैं।

Fredun Pharmaceuticals शेयर खरीदने के लिए अपने चॉइस ट्रेडिंग खाते में लॉगिन करें, या चॉइस डीमैट खाता खोल, फिर फंड जोड़ें, कंपनी का नाम खोजें, अपना ऑर्डर टाइप चुनें और ट्रेड प्लेस करें।

Fredun Pharmaceuticals शेयर का प्राइस-टू-अर्निंग्स (पी/ई) रेशियो 34.48 है। आप सापेक्ष मूल्यांकन के लिए इसकी तुलना सेक्टर के औसत से कर सकते हैं।

Fredun Pharmaceuticals शेयर का प्राइस-टू-बुक (पी/बी) रेशियो 4.23 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

Fredun Pharmaceuticals शेयर का प्राइस-टू-बुक (पी/बी) रेशियो 3.48 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

Fredun Pharmaceuticals का मार्केट कैप 973.24 CR है। यह कंपनी के आकार की श्रेणी और ट्रेडिंग लिक्विडिटी को दर्शाता है।

Fredun Pharmaceuticals शेयर का 52 सप्ताह का उच्चतम और न्यूनतम मूल्य 2141.00 और 655.20 है। ये मूल्य मूल्य सीमाएं, ट्रेडिंग रेंज, अस्थिरता, संभावित सपोर्ट/रेजिस्टेंस और मूल्य गति को दर्शाते हैं।

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost